Ling Xu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Clinical and translational medicine

Cell death discovery

Journal of hematology & oncology

ImmunoTargets and therapy

Jinan University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jinan University May 01 2018

China

Post Doctor :: The first affiliated hospital of Jinan University

Publications

Yuchen Li, Yinfeng Gu, Pengyue Yang, Yan Wang, Xibao Yu, Yangqiu Li, Zhenyi Jin, Ling Xu
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer. ImmunoTargets and therapy 13 (2024)
Xibao Yu, Yuchen Li, Pengyue Yang, Yan Wang, Xuan Liu, Letong Cai, Jing Lai, Yue Zhang, Xianfeng Zha, Grzegorz Krzysztof Przybylski, Ling Xu, Yangqiu Li
BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis. Clinical and translational medicine 14 (2) (2024)
Xibao Yu, Yuchen Li, Pengyue Yang, Yan Wang, Xuan Liu, Letong Cai, Jing Lai, Yue Zhang, Xianfeng Zha, Grzegorz Krzysztof Przybylski, Ling Xu, Yangqiu Li
BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis. Clinical and translational medicine 14 (2) (2024)
Xibao Yu, Yuchen Li, Pengyue Yang, Yan Wang, Xuan Liu, Letong Cai, Jing Lai, Yue Zhang, Xianfeng Zha, Grzegorz Krzysztof Przybylski, Ling Xu, Yangqiu Li
BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis. Clinical and translational medicine 14 (2) (2024)
Xibao Yu, Yan Wang, Jiaxiong Tan, Yuchen Li, Pengyue Yang, Xuan Liu, Jing Lai, Yue Zhang, Letong Cai, Yinfeng Gu, Ling Xu, Yangqiu Li
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell death discovery 10 (1) (2024)
Xibao Yu, Yan Wang, Jiaxiong Tan, Yuchen Li, Pengyue Yang, Xuan Liu, Jing Lai, Yue Zhang, Letong Cai, Yinfeng Gu, Ling Xu, Yangqiu Li
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell death discovery 10 (1) (2024)
Yuchen Li, Yinfeng Gu, Pengyue Yang, Yan Wang, Xibao Yu, Yangqiu Li, Zhenyi Jin, Ling Xu
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer. ImmunoTargets and therapy 13 (2024)
Letong Cai, Yuchen Li, Jiaxiong Tan, Ling Xu, Yangqiu Li
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. Journal of hematology & oncology 16 (1) (2023)
Letong Cai, Yuchen Li, Jiaxiong Tan, Ling Xu, Yangqiu Li
Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. Journal of hematology & oncology 16 (1) (2023)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Ming Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial. Clinical and translational medicine 12 (4) (2022)
Yi-Kai Zhang, Xiangbo Zeng, Xianfeng Zha, Jing Lai, Guangxiao Tan, Shaohua Chen, Xibao Yu, Yangqiu Li, Ling Xu
Correlation of the transcription factors IRF4 and BACH2 with the abnormal NFATC1 expression in T cells from chronic myeloid leukemia patients. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial. Cancer immunology, immunotherapy : CII (2022)
Xiangbo Zeng, Danlin Yao, Lian Liu, Yikai Zhang, Jing Lai, Jun Zhong, Xianfeng Zha, Yuhong Lu, Zhenyi Jin, Shaohua Chen, Yangqiu Li, Ling Xu
Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT+ NK cells may be related to poor outcome in acute myeloid leukemia. Asia-Pacific journal of clinical oncology (2021)
Xiaofang Wang, Yanjuan Chen, Zongcheng Li, Bingyan Huang, Ling Xu, Jing Lai, Yuhong Lu, Xianfeng Zha, Bing Liu, Yu Lan, Yangqiu Li
Single-Cell RNA-Seq of T Cells in B-ALL Patients Reveals an Exhausted Subset with Remarkable Heterogeneity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (19) (2021)
Danlin Yao, Ling Xu, Lian Liu, Xiangbo Zeng, Juan Zhong, Jing Lai, Runhui Zheng, Zhenyi Jin, Shaohua Chen, Xianfeng Zha, Xin Huang, Yuhong Lu
Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia. BioMed research international 2020 (2020)
Zhenyi Jin, Tianbi Lan, Yun Zhao, Jinxia Du, Jie Chen, Jing Lai, Ling Xu, Shaohua Chen, Xueyun Zhong, Xiuli Wu, Yangqiu Li
Higher TIGIT+CD226- γδ T cells in Patients with Acute Myeloid Leukemia. Immunological investigations (2020)
Yan Xu, Ling Xu, Cunte Chen, Yi-Kai Zhang, Chengwu Zeng, Zhenyi Jin, Shaohua Chen, Bo Li, Xianfeng Zha, Zhinan Yin, Yangqiu Li
Age-Related Immune Profile of the T Cell Receptor Repertoire, Thymic Recent Output Function, and miRNAs. BioMed research international 2020 (2020)

Ling Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ling Xu